These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29498445)

  • 1. Impact of preoperative BRCA1/2 testing on surgical decision making in patients with newly diagnosed breast cancer.
    Yadav S; Jinna S; Pereira-Rodrigues O; Reeves A; Campian S; Sufka A; Zakalik D
    Breast J; 2018 Jul; 24(4):541-548. PubMed ID: 29498445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative genetic testing affects surgical decision making in breast cancer patients.
    Lokich E; Stuckey A; Raker C; Wilbur JS; Laprise J; Gass J
    Gynecol Oncol; 2014 Aug; 134(2):326-30. PubMed ID: 24910453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients.
    Schwartz MD; Lerman C; Brogan B; Peshkin BN; Halbert CH; DeMarco T; Lawrence W; Main D; Finch C; Magnant C; Pennanen M; Tsangaris T; Willey S; Isaacs C
    J Clin Oncol; 2004 May; 22(10):1823-9. PubMed ID: 15067026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of genetic testing in BRCA1/2 and PALB2-Associated breast cancer: Preoperative result disclosure increases uptake of risk-reducing mastectomy and reduces unnecessary exposure to radiotherapy.
    Apostolova C; Ferroum A; Alhassan B; Prakash I; Basik M; Boileau JF; Martel K; Meterissian S; Villareal Corpuz V; Wong N; Foulkes WD; Wong SM
    Eur J Surg Oncol; 2024 Jun; 50(6):108324. PubMed ID: 38636249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation.
    Stolier AJ; Fuhrman GM; Mauterer L; Bolton JS; Superneau DW
    Breast J; 2004; 10(6):475-80. PubMed ID: 15569201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative risk assessment among women undergoing bilateral prophylactic mastectomy for cancer risk reduction.
    Rueth NM; McMahon M; Arrington AK; Swenson K; Leach J; Tuttle TM
    Ann Surg Oncol; 2011 Sep; 18(9):2515-20. PubMed ID: 21424371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
    J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test Result.
    Metcalfe KA; Eisen A; Poll A; Candib A; McCready D; Cil T; Wright F; Demsky R; Mancuso T; Sun P; Narod SA
    Ann Surg Oncol; 2021 Sep; 28(9):4967-4973. PubMed ID: 33761021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does mainstream BRCA testing affect surgical decision-making in newly-diagnosed breast cancer patients?
    Ain Q; Richardson C; Mutebi M; George A; Kemp Z; Rusby JE
    Breast; 2023 Feb; 67():30-35. PubMed ID: 36577271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer.
    Chiba A; Hoskin TL; Hallberg EJ; Cogswell JA; Heins CN; Couch FJ; Boughey JC
    Ann Surg Oncol; 2016 Oct; 23(10):3232-8. PubMed ID: 27338744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Diagnosis before Surgery has an Impact on Surgical Decision in BRCA Mutation Carriers with Breast Cancer.
    Park S; Lee JE; Ryu JM; Kim I; Bae SY; Lee SK; Yu J; Kim SW; Nam SJ
    World J Surg; 2018 May; 42(5):1384-1390. PubMed ID: 29147896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer.
    Hamilton JG; Genoff MC; Salerno M; Amoroso K; Boyar SR; Sheehan M; Fleischut MH; Siegel B; Arnold AG; Salo-Mullen EE; Hay JL; Offit K; Robson ME
    Breast Cancer Res Treat; 2017 Apr; 162(2):297-306. PubMed ID: 28150129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative Panel Testing for Hereditary Cancer Syndromes Does Not Significantly Impact Time to Surgery for Newly Diagnosed Breast Cancer Patients Compared with BRCA1/2 Testing.
    Murphy AE; Hussain L; Ho C; Dunki-Jacobs E; Lee D; Tameron A; Huelsman K; Rice C; Wexelman BA
    Ann Surg Oncol; 2017 Oct; 24(10):3055-3059. PubMed ID: 28766202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical and financial implications of genetic counseling and requests for concurrent prophylactic mastectomy.
    Murphy RX; Adkinson JM; Namey T; Eid S; Bleznak A
    Ann Plast Surg; 2010 May; 64(5):684-7. PubMed ID: 20395792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 Genes.
    Welsh JL; Hoskin TL; Day CN; Thomas AS; Cogswell JA; Couch FJ; Boughey JC
    Ann Surg Oncol; 2017 Oct; 24(10):3067-3072. PubMed ID: 28766224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of risk-reducing surgery in BRCA gene carriers in Wales, UK.
    Long J; Evans TG; Bailey D; Lewis MH; Gower-Thomas K; Murray A
    Breast J; 2018 Jul; 24(4):580-585. PubMed ID: 29286205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
    Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of Expedited Hereditary Cancer Testing in the Surgical Management of Patients with a New Breast Cancer Diagnosis.
    Theobald KA; Susswein LR; Marshall ML; Roberts ME; Mester JL; Speyer D; Williams RNW; Knapke SC; Solomon SR; Murphy PD; Klein RT; Hruska KS; Solomon BD
    Ann Surg Oncol; 2018 Nov; 25(12):3556-3562. PubMed ID: 30167906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast Cancer Risk Reduction Decisions of the BRCA-Positive Patient: An Observational Study at a Single Institution.
    Johns D; Agarwal J; Anderson L; Ying J; Kohlmann W
    J Womens Health (Larchmt); 2017 Jun; 26(6):702-706. PubMed ID: 27922795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid Genetic Testing for BRCA1 and BRCA2 Mutations at the Time of Breast Cancer Diagnosis: An Observational Study.
    Metcalfe KA; Eisen A; Poll A; Candib A; McCready D; Cil T; Wright F; Lerner-Ellis J; McCuaig J; Graham T; Sun P; Akbari M; Narod SA
    Ann Surg Oncol; 2021 Apr; 28(4):2219-2226. PubMed ID: 32989658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.